Skip to main content

and
  1. Article

    Erratum: Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector

    Correction to: Gene Therapy (2007) 14, 191–202. doi:10.1038/sj.gt.3302819 Since the above publication, the authors have noticed an error in the abbreviation of PMNs in Table 1. The correct table and abbreviati...

    K Oka, L M Belalcazar, C Dieker, E A Nour, P Nuno-Gonzalez, A Paul in Gene Therapy (2007)

  2. No Access

    Article

    Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector

    We examined the efficacy and host response to the adenovirus (Ad)-mediated delivery of human apolipoprotein A-I (APOA1) gene to the liver of APOA1−/− mice. Administration of a first-generation vector (FGAd-AI) re...

    K Oka, L M Belalcazar, C Dieker, E A Nour, P Nuno-Gonzalez, A Paul in Gene Therapy (2007)

  3. No Access

    Article

    Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia

    We tested the efficacy of low-density lipoprotein receptor (LDLR) therapy using helper-dependent adenovirus (HD-Ad), comparing it with that of very low-density lipoprotein receptor (VLDLR), an LDLR homolog. We...

    S Nomura, A Merched, E Nour, C Dieker, K Oka, L Chan in Gene Therapy (2004)